Significance of Reducing Blood Culture Contamination

      Blood culture contamination is a 10.1 billion dollar problem worldwide. The problem has been the subject of dozens of clinical trials and studies. More recent studies indicate that the problem may be even more financially costly than currently estimated (see Latest News). Besides the financial costs, there is a human cost. Blood culture contamination leads to Hospital Associated Infections (HAIs). These infections can lead to severe morbidity and eventually death for thousands each year. 

      Hospital Associated Infections are the target of many new initiatives from the Center for Medicare and Medicaid Services (CMS) (see Latest News). CMS is seeking to reduce payment for HAIs to increase hospital quality and reduce the incidence of preventable infections. In the future, quality assurance products such as the Clean Collect^TM Blood Collection System may be required by CMS for reimbursement from Medicare. 

       Many major companies have now recognized the problem of blood culture contamination and are emerging with new products to deal with it. These new products are designed to reinforce the standard blood culture sample collection method. Clean Collect^TM was designed to create a new standard for blood culture sample collection by incorporating the patented VCE Method into a simple blood collection procedure. Read more about the VCE Method or the Clean Collect Blood Collection Kit.   

<<Back to Clean Collect

Home | Entrepreneurs | Research | Clinical Laboratories | Careers | About Us

Contact Us | Latest News | Investor Relations

Stone Medical Corporation © 2007 All Rights Reserved.